• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Clostridium difficile: epidemiology and clinical features.

作者信息

Marrie T J, Furlong M, Faulkner R S, Sidorov J, Haldane E V, Kerr E A

出版信息

Can J Surg. 1982 Jul;25(4):438-42.

PMID:7093841
Abstract

To determine the epidemiologic features of Clostridium difficile in Halifax, Nova Scotia, the authors studied two groups of hospitalized patients, one group of outpatients and a fourth group of 54 healthy subjects. The first group consisted of 29 patients with diarrhea, whose stool was found to contain C. difficile or its cytotoxin, or both. Twenty-two underwent sigmoidoscopic examinations; of these, 18 had abnormal colonic mucosa and 6 of the 18 had pseudomembranous colitis. In the second group of 127 patients on general medical wards, 22 (17%) carried C. difficile. Thirteen of the 22 had diarrhea, and 3 had pseudomembranous colitis. Clustering of patients with C. difficile was evident. In vitro production of toxin by isolates of C. difficile from these patients was more likely if antibiotics had been given. Only 1 (4.5%) of the 22 outpatients with various gastrointestinal disorders (group 3) and none of the 54 healthy subjects (group 4) carried C. difficile. The clinical spectrum of infection with C. difficile extended from asymptomatic patients to those with nonspecific colitis and pseudomembranous colitis.

摘要

相似文献

1
Clostridium difficile: epidemiology and clinical features.
Can J Surg. 1982 Jul;25(4):438-42.
2
Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations.来自不同患者群体的艰难梭菌分离株的分离率和产毒潜力。
Gastroenterology. 1981 Jul;81(1):5-9.
3
[Investigation of the presence of Clostridium difficile in antibiotic associated diarrhea patients by culture and toxin detection methods].[采用培养和毒素检测方法调查抗生素相关性腹泻患者中艰难梭菌的存在情况]
Mikrobiyol Bul. 2007 Jan;41(1):29-37.
4
Cytotoxin and enterotoxin production by Clostridium difficile.艰难梭菌产生的细胞毒素和肠毒素
Microbiologica. 1984 Oct;7(4):375-9.
5
Lack of value of repeat stool testing for Clostridium difficile toxin.艰难梭菌毒素重复粪便检测的价值缺失
Am J Med. 2006 Apr;119(4):356.e7-8. doi: 10.1016/j.amjmed.2005.08.026.
6
Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study.成人艰难梭菌相关性腹泻和结肠炎。一项前瞻性病例对照流行病学研究。
Arch Intern Med. 1986 Jan;146(1):95-100.
7
Clostridium difficile infection frequency in patients with nosocomial infections or using antibiotics.医院感染患者或使用抗生素患者中艰难梭菌感染的频率。
Hepatogastroenterology. 2007 Sep;54(78):1720-4.
8
The diagnosis and treatment of Clostridium difficile in antibiotic-associated diarrhea.艰难梭菌在抗生素相关性腹泻中的诊断与治疗
Hepatogastroenterology. 1999 Jan-Feb;46(25):343-8.
9
[The frequency of Clostridium difficile toxin in neutropenic and non-neutropenic patients with antibiotic-associated diarrhea and analysis of the risk factors].[中性粒细胞减少和非中性粒细胞减少的抗生素相关性腹泻患者中艰难梭菌毒素的频率及危险因素分析]
Mikrobiyol Bul. 2008 Oct;42(4):573-83.
10
Clostridium difficile colitis.艰难梭菌结肠炎
Adv Intern Med. 1984;29:85-107.

引用本文的文献

1
Clostridium difficile: clinical disease and diagnosis.艰难梭菌:临床疾病与诊断
Clin Microbiol Rev. 1993 Jul;6(3):251-65. doi: 10.1128/CMR.6.3.251.
2
Clostridium difficile colitis secondary to intravenous vancomycin.静脉注射万古霉素继发艰难梭菌结肠炎
Dig Dis Sci. 1989 Jan;34(1):148-9. doi: 10.1007/BF01536172.
3
Restriction endonuclease analysis of nosocomial isolates of Clostridium difficile.艰难梭菌医院分离株的限制性内切酶分析
J Clin Microbiol. 1987 Nov;25(11):2168-72. doi: 10.1128/jcm.25.11.2168-2172.1987.